Osteoporosis Drugs: Technologies and Global Markets

May 20, 2010

Wellesley, Mass. – According to a new technical market research report, OSTEOPOROSIS  DRUGS: TECHNOLOGIES AND GLOBAL MARKETS (PHM064A) from BCC Research (www.bccresearch.com), the value of the market for osteoporosis drugs was an estimated $8.1 billion in 2009, but is expected to increase to more than $9.7 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 3.8%.

The largest regional segment of the market, the United States, is projected to increase at a CAGR of 4.5% to $4.8 billion in 2014, after being valued at an estimated $3.9 billion in 2009.

The European Union segment is estimated at nearly $2.5 billion in 2009, and is expected to increase at a CAGR of 2.5% to reach $2.8 billion in 2014.

The Rest of the World segment is expected to have a 5-year CAGR of 4.1%, with values of nearly $1.7 billion in 2009 and nearly $2.1 billion in 2014.

Osteoporosis is a skeletal disorder experiencing increasing prevalence globally, due mainly to the aging of the population and the increasing life expectancy worldwide. Osteoporosis fractures are a major cause of disability and morbidity, particularly among older people, and lead to decreased quality of life and increased costs due to disability and need for assisted living.

Prescription drugs for this indication could have great commercial success; four currently marketed drugs in this indication each had global revenues of more than $1 billion at some point in its life cycle.  Additionally, several new drugs are projected to enter the market through 2014 and are expected to contribute to the overall osteoporosis market growth.

This study report provides an assessment of the current market status, along with an analysis of the patient population, marketed drugs, market revenues, and company shares. The unmet needs of the osteoporosis market, and the challenges that companies must overcome to compete in this market, along with the future trends that shape the industry are also discussed.

The report provides information that is useful for business planners, market researchers, marketers, business developers, investors, venture capitalists, consultants, and anyone who wants to understand or invest in this market. The information is also useful for technology licensing and scientific research and development purposes.

Osteoporosis Drugs: Technologies and Global Markets( PHM064A )
Publish Date: May 2010    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.